BBA
ACOR

Baker Bros. Advisors’s Acorda Therapeutics ACOR Stock Holding History

Baker Bros. Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-18,605
Closed -$6.41M – 107
2019
Q3 		$6.41M Buy
18,605
+1,845
+11% +$1M 0.04% 58
2019
Q2 		$15.4M Buy
16,760
+14,326
+589% +$17.6M 0.1% 43
2019
Q1 		$3.88M Buy
+2,434
New +$4.38M 0.02% 66
2018
Q3 		– Sell
-1,443
Closed -$4.97M – 117
2018
Q2 		$4.97M Buy
+1,443
New +$4.42M 0.04% 75
2018
Q1 		– Sell
-1,716
Closed -$4.42M – 121
2017
Q4 		$4.42M Sell
1,716
-2,613
-60% -$7.43M 0.04% 84
2017
Q3 		$12.3M Buy
+4,329
New +$11.4M 0.1% 50
2017
Q2 		– Sell
-27,515
Closed -$69.3M – 122
2017
Q1 		$69.3M Hold
27,515
– – 0.57% 17
2016
Q4 		$62.1M Sell
27,515
-2,994
-10% -$7.12M 0.61% 18
2016
Q3 		$76.4M Hold
30,509
– – 0.69% 16
2016
Q2 		$93.4M Hold
30,509
– – 0.98% 12
2016
Q1 		$96.8M Buy
30,509
+675
+2% +$2.8M 1.02% 12
2015
Q4 		$153M Buy
29,834
+20,693
+226% +$90.4M 1.27% 13
2015
Q3 		$29.1M Buy
9,141
+2,983
+48% +$11.6M 0.27% 29
2015
Q2 		$24.6M Hold
6,158
– – 0.22% 44
2015
Q1 		$24.6M Sell
6,158
-138
-2% -$632K 0.2% 39
2014
Q4 		$30.9M Buy
6,296
+18
+0.3% +$77.2K 0.32% 32
2014
Q3 		$25.5M Sell
6,278
-1,273
-17% -$4.78M 0.32% 30
2014
Q2 		$30.5M Sell
7,551
-782
-9% -$3.19M 0.37% 32
2014
Q1 		$37.9M Buy
+8,333
New +$33.7M 0.48% 30

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Baker Bros. Advisors's ACOR Position: Q4 2019 in Review

Baker Bros. Advisors sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 18,605 shares — an estimated $6.41M sold.

Baker Bros. Advisors first reported a position in ACOR in Q1 2014 and held it in 19 quarters. The position peaked at $153M in Q4 2015. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Baker Bros. Advisors reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Baker Bros. Advisors sold 18,605 Acorda Therapeutics shares in Q4 2019, an estimated $6.41M.
  • Baker Bros. Advisors first reported a position in Acorda Therapeutics in Q1 2014 and held it in 19 quarters.
  • Baker Bros. Advisors's Acorda Therapeutics position peaked at $153M in Q4 2015.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Baker Bros. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.